Fernwood Investment Management, LLC Neogenomics Inc Transaction History
Fernwood Investment Management, LLC
- $283 Million
- Q4 2024
A detailed history of Fernwood Investment Management, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Fernwood Investment Management, LLC holds 88,200 shares of NEO stock, worth $959,616. This represents 0.51% of its overall portfolio holdings.
Number of Shares
88,200
Previous 89,500
1.45%
Holding current value
$959,616
Previous $1.32 Million
10.08%
% of portfolio
0.51%
Previous 0.44%
Shares
19 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$214 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$155 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$71 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$67.1 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$67 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.37B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...